I 3 Pharmaceuticals, Llc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 200 Park Avenue, Warminster, Pennsylvania (PA) 18974, United States (USA)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3012763653 · DUNS 080127275
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2026-05-22
- NAIBioresearch Monitoring2024-11-22
- VAIDrug Quality Assurance2023-03-03
- VAIDrug Quality Assurance2018-12-21
Drugs this plant is listed as making
8 distinct drugs across 22 products name this site in their FDA label.
- Gaunfacinei3 Pharmaceuticals, LLC
- isosorbide dinitrate and hydralazine hydrochlorideA2A Integrated Pharmaceuticals
- MaravirocA2A Integrated Pharmaceuticals
- PosaconazoleA2A Integrated Pharmaceuticals
- RamelteonTruPharma, LLC
- RanolazineA2A Integrated Pharmaceuticals
- RifabutinA2A Integrated Pharmaceuticals
- Selegiline Hydrochloridei3 Pharmaceuticals, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.